Omeros (NASDAQ: OMER) announced the nationwide commercial availability of Omidria™ (phenylephrine and ketorolac injection) 1%/0.3%. Omidria is the first ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE